News Announcement

Aspira Pathlab & Diagnostics: Unaudited Financial Results For The Quarter Ended December 31 2020.

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose a copy of the statements containing the unaudited Financial Results of the Company for the quarter ended December 31 2020 which has been approved at the meeting of the Board of Directors held today.
We also enclose a copy of the Limited Review Report for the quarter ended December 31 2020 issued by the Statutory Auditors.
The Board Meeting commenced at 3.30 pm and concluded at 5.00 pm.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds